Medicine, prevention, nutrition, mental health, healthy aging, health technology, health policy, and the regulation of supplements.
The World Health Organization's 2026 healthy-diet guidance says free sugars should provide less than 10 percent of daily energy. Fructose has a distinct liver pathway, but the evidence does not support treating it as the only source of sugary drinks' metabolic risk.
Pain in the groin, outer hip or buttock can point clinicians toward different structures, but location alone cannot identify the cause. Sudden severe pain, inability to bear weight, fever or a hot swollen hip requires prompt assessment before home care.
Taiwan completed a tender in May 2026 for up to 7,050,150 publicly funded trivalent influenza vaccine doses for the 2026-27 season. The program adds adjuvanted and high-dose vaccines for older care-home residents, but its launch date had not been published by July 30.
Families preparing for a new school term can reset sleep routines, watch for vision problems and compare vaccination records with the schedule where they live. Persistent school refusal or any immediate risk of self-harm calls for professional help rather than a longer checklist.
World Health Organization guidance tells parents to seek medical advice when a child with hand, foot and mouth disease develops high fever, vomiting, lethargy or limb weakness. Sudden weakness or trouble breathing, swallowing or speaking requires urgent assessment, while prevention centers on soap-and-water handwashing and cleaning shared surfaces.
The World Health Organization's updated care framework asks primary-care teams to assess changes in older adults' physical and mental capacities alongside their medical conditions. Walking speed, chair rises and grip strength can inform that review, but none provides a diagnosis or proves what caused a decline.
A systematic review of 25 randomized trials found that resistance training improved strength and physical performance in older adults with frailty or sarcopenia. The trials varied widely, and their results do not provide a single exercise prescription for every older person.
A 2026 analysis of three cohorts found that lean adults with MASLD had higher relative rates of liver-related events and death than non-lean patients. Normal liver enzyme results cannot rule out fibrosis, while treatment goals differ according to weight, fibrosis and other metabolic risks.
A 2024 systematic review found that explainable AI increased clinicians' trust in five of 10 empirical studies, while two reported mixed effects. A COVID-19 drug-repurposing project shows how an inspectable workflow can support expert review, but explanations do not establish clinical validity.
A 2024 BMJ umbrella review linked greater exposure to ultra-processed food with 32 adverse health outcomes across 45 pooled analyses. NOVA can help identify industrial formulations, but it does not make every processed food unhealthy or settle the nutritional value of every product.
The American College of Rheumatology recommends against starting urate-lowering medicine for most people who have high uric acid but no gout attacks or tophi. Treatment decisions change after recurrent attacks, joint damage, kidney stones or other clinical findings.
European food-safety assessors said in 2025 that available evidence still could not establish a safe daily intake of monacolins from red yeast rice supplements. Monacolin K is structurally identical to lovastatin, and products may vary in strength and contamination risk.
European Union rules cap benzo[a]pyrene at 2.0 micrograms per kilogram and four selected polycyclic aromatic hydrocarbons at 10.0 micrograms per kilogram in most consumer oils and fats. The limits address contamination, while an IARC cancer classification does not quantify the risk from one meal or one recalled bottle.
The World Gastroenterology Organisation's 2023 guideline says probiotic benefits should be tied to a named strain or strain combination at an effective dose. A large CFU count alone cannot show that a product matches the evidence or will remain potent through its shelf life.
The AREDS2 primary analysis did not show that adding lutein and zeaxanthin reduced progression to late age-related macular degeneration. Later findings apply to people who already had intermediate disease or late disease in one eye, not to healthy screen users.
A 2025 meta-analysis of 23 randomized trials found no improvement in skin hydration, elasticity or wrinkles when researchers examined higher-quality studies separately. Favorable results were concentrated in lower-quality and pharmaceutical-company-funded trials, leaving the clinical case for collagen supplements unresolved.
A 2024 analysis of three COSMOS substudies found a small cognitive difference among older US adults assigned a daily multivitamin. The parent trial found no reduction in total cancer, cardiovascular disease or all-cause mortality.
A 2026 evidence review found that oral NMN changes NAD-related biomarkers, while its effects on health and physical function remain inconsistent. Taiwan also bars food advertising from claiming medical efficacy, making product legality a separate question from clinical benefit.
